Cargando…

The potential association between PARP14 and the SARS-CoV-2 infection (COVID-19)

Understanding the potential association between the poly (ADP-ribose) polymerase member 14 (PARP14) and the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may aid in understanding the host immunopathological response to the virus. PARP14 has an emerging role in viral infections, and th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tauber, Amanda L, Schweiker, Stephanie S, Levonis, Stephan M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Newlands Press Ltd 2021
Materias:	Special Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818771/ https://www.ncbi.nlm.nih.gov/pubmed/33467912 http://dx.doi.org/10.4155/fmc-2020-0226

Ejemplares similares

An efficient and robust HPLC method to determine the sialylation levels of human epithelial cells
por: Kim, Hyo Jeong, et al.
Publicado: (2022)

Sequence homology between human PARP14 and the SARS-CoV-2 ADP ribose 1’-phosphatase
por: Webb, Thomas E., et al.
Publicado: (2020)

Tocilizumab in patients infected by SARS-CoV2()
por: Sancho, Milagros, et al.
Publicado: (2021)

The interplay of SARS-CoV-2 and Clostridioides difficile infection
por: Khanna, Sahil, et al.
Publicado: (2021)

Pharmacogenomic considerations for repurposing of dexamethasone as a potential drug against SARS-CoV-2 infection
por: Vohra, Manik, et al.
Publicado: (2021)

Cardiovascular disease in SARS‐CoV‐2 infection
por: Sato, Kei, et al.
Publicado: (2021)

SARS-CoV-2 and Chlamydia pneumoniae co-infection: A review of the literature
por: Frutos, María Celia, et al.
Publicado: (2022)

Inflammation, malnutrition, and SARS-CoV-2 infection: A disastrous combination()
por: Carretero Gómez, J., et al.
Publicado: (2020)

Transmission and clinical characteristics of asymptomatic patients with SARS-CoV-2 infection
por: Tan, Jie, et al.
Publicado: (2020)

Is there any effect of flu vaccine on the SARS-CoV-2 infected patients?
por: El-Qutob, D., et al.
Publicado: (2022)

Is there any effect of flu vaccine on the SARS-CoV-2 infected patients?
por: El-Qutob, D., et al.
Publicado: (2022)

SARS-CoV-2 Variants and Vaccines
por: Krause, Philip R., et al.
Publicado: (2021)

Glycosylation is a key in SARS-CoV-2 infection
por: Reis, Celso A., et al.
Publicado: (2021)

Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab()
por: Figuero-Pérez, Luis, et al.
Publicado: (2021)

Air contamination with SARS-CoV-2 in the operating room
por: Hirota, Kazuyoshi
Publicado: (2020)

Bioinformatical study on the proteomics and evolution of SARS-CoV
por: Liu, Shuqun, et al.
Publicado: (2003)

Therapeutische Nanobodies gegen SARS-CoV-2
por: Güttler, Thomas, et al.
Publicado: (2022)

A standardized definition of placental infection by SARS-CoV-2, a consensus statement from the National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development SARS-CoV-2 Placental Infection Workshop
por: Roberts, Drucilla J., et al.
Publicado: (2021)

Reply to: SARS‐CoV‐2 as a Potential Trigger of Neurodegenerative Diseases
por: Outeiro, Tiago F., et al.
Publicado: (2020)

(18)F-FDG-PET/CT in SARS-CoV-2 infection and its sequelae()
por: Rodríguez-Alfonso, B., et al.
Publicado: (2021)

Are hemoglobin-derived peptides involved in the neuropsychiatric symptoms caused by SARS-CoV-2 infection?
por: Mendonça, Michelle Mendanha, et al.
Publicado: (2022)

Interpretation of laboratory tests for prevention of the SARS-CoV-2 transmission
por: Masui, Kenichi
Publicado: (2020)

Control of SARS-CoV-2 transmission in orthodontic practice
por: Guo, Yongwen, et al.
Publicado: (2020)

Repurposing and computational design of PARP inhibitors as SARS-CoV-2 inhibitors
por: Rampogu, Shailima, et al.
Publicado: (2023)

Therapeutic Significance of microRNA-Mediated Regulation of PARP-1 in SARS-CoV-2 Infection
por: Dash, Sabyasachi, et al.
Publicado: (2021)

SARS-CoV-2 spike protein seropositivity from vaccination or infection does not cause sterility
por: Morris, Randy S.
Publicado: (2021)

Cell and animal models of SARS-CoV-2 pathogenesis and immunity
por: Leist, Sarah R., et al.
Publicado: (2020)

Current status of therapeutic approaches and vaccines for SARS-CoV-2
por: Wahid, Braira, et al.
Publicado: (2021)

The mutational spectrum of SARS-CoV-2 genomic and antigenomic RNA
por: Zhao, Lele, et al.
Publicado: (2022)

Proteomics research of SARS-CoV-2 and COVID-19 disease
por: Zhang, Nan, et al.
Publicado: (2022)

Myocarditis related SARS-CoV-2 infection or vaccination: an expert consensus statement on its diagnosis and management
por: Barreiro-Pérez, Manuel, et al.
Publicado: (2023)

Outcomes of SARS‐CoV‐2 Infections in Patients with Neurodegenerative Diseases in the LEOSS Cohort
por: Huber, Meret K., et al.
Publicado: (2021)

Preliminary pragmatic lessons from the SARS-CoV-2 pandemic in France
por: Gauss, Tobias, et al.
Publicado: (2020)

Pros and cons of the application of evolutionary theories to the evolution of SARS-CoV-2
por: Li, Yue, et al.
Publicado: (2020)

Assessment of Specimen Pooling to Conserve SARS CoV-2 Testing Resources
por: Abdalhamid, Baha, et al.
Publicado: (2020)

Position statement of the Spanish Society of Nephrology on the SARS-CoV-2 vaccines()
por: Sánchez-Álvarez, Emilio, et al.
Publicado: (2021)

Recommendations on cardiopulmonary resuscitation in patients with suspected or confirmed SARS-CoV-2 infection (COVID-19). Executive summary()()
por: Rodríguez Yago, M.A., et al.
Publicado: (2020)

Etablierung der PCR-basierten SARS-CoV-2-Testung im Hochdurchsatz
por: Klussmeier, Anja, et al.
Publicado: (2020)

Public Health Interventions to Mitigate Early Spread of SARS-CoV-2 in Poland
por: Pinkas, Jarosław, et al.
Publicado: (2020)

SARS-CoV-2: what it is, how it acts, and how it manifests in imaging studies()
por: Fernández-Pérez, G.C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g197bhqgeq9tme5ao4l3c8230q